A 39-year-old pregnant woman at 16 weeks gestation recently underwent a quad-screen which revealed elevated beta-hCG, elevated inhibin A, decreased alpha-fetoprotein, and decreased estradiol. An ultrasound was performed which found increased nuchal translucency. Which of the following is recommended for diagnosis?
Q42
A 16-year-old female presents to the physician for delayed onset of menstruation. She reports that all of her friends have experienced their first menses, and she wonders whether "something is wrong with me." The patient is a sophomore in high school and doing well in school. Her past medical history is significant for an episode of streptococcal pharyngitis six months ago, for which she was treated with oral amoxicillin. The patient is in the 35th percentile for weight and 5th percentile for height. On physical exam, her temperature is 98.7°F (37.1°C), blood pressure is 112/67 mmHg, pulse is 71/min, and respirations are 12/min. The patient has a short neck and wide torso. She has Tanner stage I breast development and pubic hair with normal external female genitalia. On bimanual exam, the vagina is of normal length and the cervix is palpable.
Which of the following is the most accurate test to diagnose this condition?
Q43
A 19-year-old female presents with a malodorous vaginal discharge. She notes that the odor is more prominent after sexual intercourse. She is sexually active with one partner and uses barrier contraception. Her past medical history is significant only for community-acquired pneumonia treated with antibiotics 2 months ago. The vital signs were as follows: blood pressure, 110/70 mm Hg; heart rate, 68/min; respiratory rate, 12/min; and temperature, 36.6℃ (97.9℉). The physical examination was normal. On gynecologic examination, the vaginal walls and cervix appeared normal. There was a gray, thin, homogeneous discharge with bubbles. The pH of the discharge was approximately 6.0. Which of the following findings would be expected on further investigation of this patient?
Q44
A 47-year-old woman presents with abnormal vaginal bleeding. She reports that she has had heavy, irregular periods for the past 6 months. Her periods, which normally occur every 28 days, are sometimes now only 2-3 weeks apart, last 7-10 days, and has spotting in between menses. Additionally, her breasts feel enlarged and tender. She denies abdominal pain, dysuria, dyspareunia, constipation, or abnormal vaginal discharge. The patient has a history of depression and hyperlipidemia. She takes fluoxetine and atorvastatin. She is a widow and has 2 healthy children. She works as an accountant. The patient says she drinks a half bottle of wine every night to help her calm down after work and to help her sleep. She denies tobacco or illicit drug use. She is not currently sexually active. Physical examination reveals spider angiomata and mild ascites. The left ovary is palpable but non-tender. A thickened endometrial stripe and a left ovarian mass are noted on ultrasound. A mammogram, chest radiograph, and CT abdomen/pelvis are pending. Which of the following tumor markers is associated with the patient’s most likely diagnosis?
Q45
A 37-year-old G3P2 is referred to a gynecologist by her physician to follow-up on the results of some screening tests. She has a history of 1 medical abortion and 2 vaginal deliveries. The most recent labor, which occurred at 31 years of age, was induced at 41 weeks gestation with prostaglandin application to the cervix, and was complicated by a cervical laceration. A Pap smear obtained 1 year ago showed a low-grade intraepithelial lesion (LSIL), but HPV testing was negative. Currently, the patient reports no symptoms. Her husband is her only sexual partner. She uses oral contraception. She does not have any co-existing diseases. The HPV test performed at the patient's last evaluation by her physician was positive. The Pap smear results were as follows:
Specimen adequacy: satisfactory for evaluation
Interpretation: high-grade squamous intraepithelial lesion (HSIL)
A colposcopic examination is performed, but deemed inadequate due to cervical scarring with a partial obliteration of the external os. The lesion can be seen at the 7–8 o'clock position occupying 1/2 of the visible right lower quadrant of the cervix with a dense acetowhite epithelium and coarse punctuation. The cervical scar interferes with identification of the margins and extension of the lesion into the cervical canal. Which of the following would be the most appropriate next step in the management of this patient?
Q46
A 58-year-old woman presents to the physician for a routine gynecological visit. She denies any acute issues and remarks that she has not been sexually active for the past year. Her last Pap test was negative for any abnormal cytology. A pelvic examination and Pap test is performed at the current visit with no remarkable findings. Which of the following approaches to cervical cancer screening is most appropriate for this patient?
Q47
A 45-year-old woman, gravida 3, para 2, at 18 weeks' gestation comes to the physician for a prenatal visit. Ultrasonography at a previous visit when she was at 12 weeks' gestation showed a hypoplastic nasal bone. Pelvic examination shows a uterus consistent in size with an 18-week gestation. Maternal serum studies show low α-fetoprotein and free estriol concentrations, and increased inhibin A and β-hCG concentrations. Physical examination of the infant after delivery is most likely to show which of the following findings?
Q48
A 55-year-old postmenopausal woman comes to the physician for a screening Pap smear. She has no history of serious illness. Her last Pap smear was 10 years ago and showed no abnormalities. She has smoked one-half pack of cigarettes daily for 20 years and drinks 3 bottles of wine per week. She is sexually active with multiple male partners and uses condoms inconsistently. Her paternal grandmother had ovarian cancer and her maternal aunt had breast cancer. Pelvic examination shows multiple red, fleshy polypoid masses on the anterior vaginal wall. A biopsy is obtained and histology shows large cells with abundant clear cytoplasm. Which of the following is the most significant risk factor for this diagnosis?
Q49
A 27-year-old G1P0 female presents for her first prenatal visit. She is in a monogamous relationship with her husband, and has had two lifetime sexual partners. She has never had a blood transfusion and has never used injection drugs. Screening for which of the following infections is most appropriate to recommend this patient?
Q50
An 18-year-old woman presents for a routine check-up. She is a college student with no complaints. She has a 2 pack-year history of smoking and consumes alcohol occasionally. Her sexual debut was at 15 years of age and has had 2 sexual partners. She takes oral contraceptives and uses barrier contraception. Her family history is significant for cervical cancer in her aunt. Which of the following statements regarding cervical cancer screening in this patient is correct?
Screening tests US Medical PG Practice Questions and MCQs
Question 41: A 39-year-old pregnant woman at 16 weeks gestation recently underwent a quad-screen which revealed elevated beta-hCG, elevated inhibin A, decreased alpha-fetoprotein, and decreased estradiol. An ultrasound was performed which found increased nuchal translucency. Which of the following is recommended for diagnosis?
A. Biopsy and pathologic examination of fetus
B. Confirmatory amniocentesis and chromosomal analysis of the fetal cells (Correct Answer)
C. Fetus is normal, continue with pregnancy as expected
D. Maternal karyotype
E. Cell-free fetal DNA analysis
Explanation: ***Confirmatory amniocentesis and chromosomal analysis of the fetal cells***
- The combination of **quad-screen results** (elevated 𝛽-hCG, elevated inhibin A, decreased AFP, decreased estradiol) and **increased nuchal translucency** strongly suggests an aneuploidy, particularly **Down Syndrome (Trisomy 21)**.
- **Amniocentesis** is a **diagnostic procedure** that provides fetal cells for definitive chromosomal analysis (karyotyping), confirming or ruling out aneuploidy with high accuracy.
*Biopsy and pathologic examination of fetus*
- A **fetal biopsy** is generally not a standard diagnostic test for aneuploidy and carries higher risks than amniocentesis or chorionic villus sampling (CVS).
- This procedure would typically be considered for specific fetal anomalies requiring tissue diagnosis, not for confirming chromosomal disorders.
*Fetus is normal, continue with pregnancy as expected*
- The abnormal **quad-screen results** and **increased nuchal translucency** are significant indicators of potential chromosomal abnormalities, making it unlikely that the fetus is normal.
- Ignoring these findings could lead to the birth of a child with an undiagnosed genetic condition.
*Maternal karyotype*
- A **maternal karyotype** evaluates the mother's chromosomes to identify balanced translocations or other inherited chromosomal abnormalities that could increase the risk in offspring.
- While helpful for identifying a parental genetic cause, it does not directly diagnose the fetal condition; a fetal sample is still needed for that.
*Cell-free fetal DNA analysis*
- **Cell-free fetal DNA (cfDNA) analysis** is a **screening test** with high sensitivity and specificity for common aneuploidies, but it is not a diagnostic test.
- While it can guide further investigation, a positive cfDNA result still requires a **confirmatory diagnostic procedure** like amniocentesis or CVS before making definitive clinical decisions.
Question 42: A 16-year-old female presents to the physician for delayed onset of menstruation. She reports that all of her friends have experienced their first menses, and she wonders whether "something is wrong with me." The patient is a sophomore in high school and doing well in school. Her past medical history is significant for an episode of streptococcal pharyngitis six months ago, for which she was treated with oral amoxicillin. The patient is in the 35th percentile for weight and 5th percentile for height. On physical exam, her temperature is 98.7°F (37.1°C), blood pressure is 112/67 mmHg, pulse is 71/min, and respirations are 12/min. The patient has a short neck and wide torso. She has Tanner stage I breast development and pubic hair with normal external female genitalia. On bimanual exam, the vagina is of normal length and the cervix is palpable.
Which of the following is the most accurate test to diagnose this condition?
A. Serum FSH and LH levels
B. Karyotype analysis (Correct Answer)
C. Buccal smear for Barr bodies
D. Serum testosterone level
E. Serum 17-hydroxyprogesterone level
Explanation: ***Karyotype analysis***
- The patient's presentation with **primary amenorrhea**, **short stature**, and phenotypic features like a **short neck** and **wide torso** are highly suggestive of **Turner syndrome**. Karyotype analysis is the definitive test to confirm this diagnosis by identifying the characteristic **45,X monosomal karyotype**.
- A karyotype directly analyzes the **chromosomal complement**, allowing for the detection of **aneuploidy** or structural abnormalities which are the underlying cause of Turner syndrome.
*Serum FSH and LH levels*
- While **elevated FSH and LH levels** would be expected in Turner syndrome due to **gonadal dysgenesis**, indicating **hypergonadotropic hypogonadism**, these hormonal levels are not diagnostic on their own.
- High FSH and LH levels indicate **ovarian failure** but do not definitively identify the underlying cause, which could be various conditions leading to hypogonadism.
*Buccal smear for Barr bodies*
- A buccal smear for **Barr bodies** (inactive X chromosomes) can indicate the number of X chromosomes. In Turner syndrome (45,X), **no Barr bodies** would be found, but this test is **less reliable** and **less specific** than a full karyotype.
- A buccal smear cannot detect all forms of Turner syndrome, such as mosaicism (e.g., 45,X/46,XX), which a karyotype would identify.
*Serum testosterone level*
- A **serum testosterone level** would be relevant if **androgen insensitivity syndrome** or another cause of virilization was suspected; however, this patient has normal external female genitalia and no signs of virilization.
- Low testosterone is expected in females and would not explain primary amenorrhea with these specific physical findings.
*Serum 17-hydroxyprogesterone level*
- **Serum 17-hydroxyprogesterone** is used to screen for **congenital adrenal hyperplasia (CAH)**, which might present with primary amenorrhea if severe, but typically involves **virilization** (ambiguous genitalia, clitoromegaly), which is absent in this patient.
- The patient's physical characteristics (short stature, short neck, wide torso) are not consistent with CAH.
Question 43: A 19-year-old female presents with a malodorous vaginal discharge. She notes that the odor is more prominent after sexual intercourse. She is sexually active with one partner and uses barrier contraception. Her past medical history is significant only for community-acquired pneumonia treated with antibiotics 2 months ago. The vital signs were as follows: blood pressure, 110/70 mm Hg; heart rate, 68/min; respiratory rate, 12/min; and temperature, 36.6℃ (97.9℉). The physical examination was normal. On gynecologic examination, the vaginal walls and cervix appeared normal. There was a gray, thin, homogeneous discharge with bubbles. The pH of the discharge was approximately 6.0. Which of the following findings would be expected on further investigation of this patient?
A. Numerous gram-positive rod-shaped bacteria on Gram stain
B. Bacteria-coated epithelial cells on wet mount microscopy (Correct Answer)
C. Gram-positive diplococci on Gram stain
D. Negative whiff test
E. Motile protozoa on wet mount microscopy
Explanation: ***Bacteria-coated epithelial cells on wet mount microscopy***
- This finding, specifically **clue cells**, is a hallmark of **bacterial vaginosis (BV)**. Clue cells are vaginal epithelial cells covered in bacteria, indicating the overgrowth of anaerobic bacteria and a decrease in normal lactobacilli.
- The patient's symptoms of a **malodorous discharge** that worsens after intercourse, a **gray, thin, homogeneous discharge**, and a **vaginal pH of 6.0** are all classic signs of bacterial vaginosis.
*Numerous gram-positive rod-shaped bacteria on Gram stain*
- **Normal vaginal flora** is dominated by **Gram-positive rods (lactobacilli)**. In bacterial vaginosis, these beneficial bacteria are significantly reduced, while anaerobic bacteria proliferate.
- An overgrowth of Gram-positive rods would suggest a healthy vaginal flora, conflicting with the presented symptoms and a high vaginal pH.
*Gram-positive diplococci on Gram stain*
- **Gram-positive diplococci** isolated from vaginal discharge could suggest an infection with organisms like **Streptococcus pneumoniae** or **Staphylococcus aureus**, which are not typical causes of malodorous vaginal discharge or bacterial vaginosis.
- Infections like Neisseria gonorrhoeae, which can cause cervicitis, are characterized by **Gram-negative diplococci**.
*Negative whiff test*
- The **whiff test** involves adding potassium hydroxide (KOH) to vaginal discharge to detect a fishy odor. A **positive whiff test** is a characteristic sign of bacterial vaginosis due to the production of amines by anaerobic bacteria.
- A negative whiff test would argue against a diagnosis of bacterial vaginosis despite the other clinical findings.
*Motile protozoa on wet mount microscopy*
- The presence of **motile protozoa**, specifically **Trichomonas vaginalis**, is indicative of trichomoniasis, another common cause of vaginitis.
- While trichomoniasis can cause a frothy discharge and elevated pH, the discharge is often described as greenish-yellow, and it would not typically present with the specific features of clue cells.
Question 44: A 47-year-old woman presents with abnormal vaginal bleeding. She reports that she has had heavy, irregular periods for the past 6 months. Her periods, which normally occur every 28 days, are sometimes now only 2-3 weeks apart, last 7-10 days, and has spotting in between menses. Additionally, her breasts feel enlarged and tender. She denies abdominal pain, dysuria, dyspareunia, constipation, or abnormal vaginal discharge. The patient has a history of depression and hyperlipidemia. She takes fluoxetine and atorvastatin. She is a widow and has 2 healthy children. She works as an accountant. The patient says she drinks a half bottle of wine every night to help her calm down after work and to help her sleep. She denies tobacco or illicit drug use. She is not currently sexually active. Physical examination reveals spider angiomata and mild ascites. The left ovary is palpable but non-tender. A thickened endometrial stripe and a left ovarian mass are noted on ultrasound. A mammogram, chest radiograph, and CT abdomen/pelvis are pending. Which of the following tumor markers is associated with the patient’s most likely diagnosis?
A. Alpha-fetoprotein
B. Estrogen
C. Testosterone
D. Carcinoembryonic antigen
E. Cancer antigen-125 (Correct Answer)
Explanation: ***Cancer antigen-125***
- The patient's presentation with **abnormal vaginal bleeding**, **breast tenderness**, **spider angiomata**, and **ascites** suggests a gynecological malignancy, possibly **ovarian cancer** with liver involvement due to chronic alcohol use. **CA-125** is the most widely used tumor marker for epithelial ovarian cancer.
- While not diagnostic on its own, elevated CA-125 levels, especially in the context of a **palpable ovarian mass** and **ascites**, strongly support the diagnosis of ovarian cancer, and it is also used for monitoring treatment response and recurrence.
*Alpha-fetoprotein*
- **Alpha-fetoprotein (AFP)** is primarily associated with **germ cell tumors**, such as **yolk sac tumors** of the ovary, and **hepatocellular carcinoma**.
- While an ovarian mass is present, the clinical picture with prominent signs of **estrogen excess** (abnormal bleeding, breast tenderness, thickened endometrial stripe) and **liver disease** (spider angiomata, ascites) does not strongly point to an AFP-secreting tumor or primary hepatocellular carcinoma without further evidence.
*Estrogen*
- Although the patient's symptoms (abnormal bleeding, breast tenderness, thickened endometrial stripe) are consistent with **estrogen excess**, estrogen itself is a **hormone**, not a tumor marker used to diagnose ovarian cancer.
- Some ovarian tumors, particularly **granulosa cell tumors**, produce estrogen, which would be reflected in elevated serum estrogen levels, but "estrogen" is not the tumor marker itself.
*Testosterone*
- **Testosterone** is primarily associated with **androgen-secreting tumors**, such as **Sertoli-Leydig cell tumors** of the ovary, which would typically present with signs of **virilization** (e.g., hirsutism, deepening voice, clitoromegaly).
- The patient's symptoms of **estrogen excess** (abnormal uterine bleeding, breast tenderness) are contrary to a testosterone-secreting tumor.
*Carcinoembryonic antigen*
- **Carcinoembryonic antigen (CEA)** is a tumor marker primarily associated with **colorectal cancer**, but it can also be elevated in other adenocarcinomas, such as those of the **breast, lung, and gastrointestinal tract**.
- While general malignancy is considered, CEA is not the primary marker for ovarian cancer, and the constellation of symptoms (especially those related to estrogen excess and possible liver involvement) points more specifically towards an ovarian origin.
Question 45: A 37-year-old G3P2 is referred to a gynecologist by her physician to follow-up on the results of some screening tests. She has a history of 1 medical abortion and 2 vaginal deliveries. The most recent labor, which occurred at 31 years of age, was induced at 41 weeks gestation with prostaglandin application to the cervix, and was complicated by a cervical laceration. A Pap smear obtained 1 year ago showed a low-grade intraepithelial lesion (LSIL), but HPV testing was negative. Currently, the patient reports no symptoms. Her husband is her only sexual partner. She uses oral contraception. She does not have any co-existing diseases. The HPV test performed at the patient's last evaluation by her physician was positive. The Pap smear results were as follows:
Specimen adequacy: satisfactory for evaluation
Interpretation: high-grade squamous intraepithelial lesion (HSIL)
A colposcopic examination is performed, but deemed inadequate due to cervical scarring with a partial obliteration of the external os. The lesion can be seen at the 7–8 o'clock position occupying 1/2 of the visible right lower quadrant of the cervix with a dense acetowhite epithelium and coarse punctuation. The cervical scar interferes with identification of the margins and extension of the lesion into the cervical canal. Which of the following would be the most appropriate next step in the management of this patient?
A. Cryoablation of the lesion
B. Punch biopsy and subsequent management based on the results
C. Laser ablation of the lesion
D. Cold-knife conization (Correct Answer)
E. Genotyping for HPV type 16 and 18 and further management based on the results
Explanation: **Cold-knife conization**
- This patient has a **high-grade squamous intraepithelial lesion (HSIL)**, positive **HPV**, and an **inadequate colposcopy** because the lesion extends into the endocervical canal, preventing visualization of the full extent of the transformation zone.
- In such cases, **cold-knife conization** is the most appropriate next step as it allows for the complete excision of the transformation zone and provides a definitive diagnosis by removing the lesion for histological evaluation, ensuring all margins can be assessed.
*Cryoablation of the lesion*
- This method is typically reserved for women with **low-grade squamous intraepithelial lesions (LSIL)** or low-grade CIN confirmed by biopsy, or in situations where definitive excisional treatment is not required.
- It is not suitable when an **inadequate colposcopy** suggests the lesion extends into the endocervical canal, where the full extent cannot be visualized and margins cannot be assessed.
*Punch biopsy and subsequent management based on the results*
- A **punch biopsy** would not be sufficient here because the colposcopy was **inadequate**, meaning the full extent of the lesion and its margins could not be visualized.
- A punch biopsy would provide only a superficial sample and would not address the concern of the lesion extending into the **endocervical canal**, which requires excisional treatment to ensure complete removal and proper evaluation of margins.
*Laser ablation of the lesion*
- Similar to cryoablation, laser ablation is generally used for **low-grade lesions** or in cases where the entire lesion and its margins are clearly visible and fully resectable.
- Given the patient's **HSIL** and **inadequate colposcopy** due to scarring and obscured margins, laser ablation would not guarantee complete eradication or adequate histological assessment of the deeper lesion.
*Genotyping for HPV type 16 and 18 and further management based on the results*
- While **HPV genotyping for types 16 and 18** is useful for risk stratification and guiding management in certain scenarios, it is not the immediate next step when an HSIL is diagnosed with an inadequate colposcopy.
- The presence of **HSIL** on cytology, combined with the inability to adequately visualize the lesion's extent during **colposcopy**, necessitates an excisional procedure like conization to rule out invasive cancer and ensure complete removal of the precancerous lesion.
Question 46: A 58-year-old woman presents to the physician for a routine gynecological visit. She denies any acute issues and remarks that she has not been sexually active for the past year. Her last Pap test was negative for any abnormal cytology. A pelvic examination and Pap test is performed at the current visit with no remarkable findings. Which of the following approaches to cervical cancer screening is most appropriate for this patient?
A. Colposcopy in 3 years
B. Pap test and HPV test in 5 years (Correct Answer)
C. Pap test only in 5 years
D. Discontinue screening until the patient becomes sexually active
E. Colposcopy at the current visit to verify Pap test results
Explanation: ***Pap test and HPV test in 5 years***
- For women aged 30-65, **co-testing with both a Pap test and HPV test every 5 years** is the preferred screening interval if both results are normal.
- This patient, at 58 years old, falls within this age range, and her prior normal Pap tests along with a normal current one, support a 5-year interval for co-testing.
*Colposcopy in 3 years*
- **Colposcopy** is a diagnostic procedure performed to further evaluate abnormal Pap test results, not a routine screening method.
- Doing a colposcopy in 3 years would be an overly aggressive approach given her history of normal screenings.
*Pap test only in 5 years*
- While a Pap test alone every 3 years is an acceptable screening option, **co-testing with HPV every 5 years** is generally preferred due to its higher sensitivity for detecting precancerous lesions.
- Omitting the HPV test would reduce the effectiveness of the screening strategy in detecting cervical cancer early.
*Discontinue screening until the patient becomes sexually active*
- **Sexual activity** is a risk factor for HPV infection, but cervical cancer screening guidelines do not link its discontinuation to a lack of sexual activity.
- Women over 65 years old with a history of adequate negative screenings may discontinue screening, but this patient is 58 and does not meet that criterion yet.
*Colposcopy at the current visit to verify Pap test results*
- A **colposcopy** is indicated for **abnormal Pap test results**, which this patient does not have.
- Performing a colposcopy in the absence of abnormal findings is unnecessary and not part of routine screening.
Question 47: A 45-year-old woman, gravida 3, para 2, at 18 weeks' gestation comes to the physician for a prenatal visit. Ultrasonography at a previous visit when she was at 12 weeks' gestation showed a hypoplastic nasal bone. Pelvic examination shows a uterus consistent in size with an 18-week gestation. Maternal serum studies show low α-fetoprotein and free estriol concentrations, and increased inhibin A and β-hCG concentrations. Physical examination of the infant after delivery is most likely to show which of the following findings?
A. Single transverse palmar crease (Correct Answer)
B. Microphthalmia
C. Ambiguous external genitalia
D. Meningomyelocele
E. Extremity lymphedema
Explanation: ***Single transverse palmar crease***
- The prenatal findings (hypoplastic nasal bone, low **α-fetoprotein** and **free estriol**, high **inhibin A** and **β-hCG**) are characteristic of **Down syndrome (Trisomy 21)**.
- A **single transverse palmar crease** (Simian crease) is a classic physical finding in infants with Down syndrome.
*Microphthalmia*
- **Microphthalmia** (abnormally small eyes) is more commonly associated with chromosomal abnormalities like **Trisomy 13 (Patau syndrome)**, not Down syndrome.
- Other features of Trisomy 13 include **holoprosencephaly**, cleft lip/palate, and polydactyly, which are not suggested by the prenatal screening.
*Ambiguous external genitalia*
- **Ambiguous external genitalia** can be associated with various genetic conditions, particularly those affecting sex hormone synthesis or differentiation (e.g., **congenital adrenal hyperplasia**).
- It is not a characteristic finding of Down syndrome.
*Meningomyelocele*
- A **meningomyelocele** is a severe form of **neural tube defect**, typically indicated by **high α-fetoprotein** levels.
- The presented serum markers show **low α-fetoprotein**, ruling out neural tube defects.
*Extremity lymphedema*
- **Extremity lymphedema** is a hallmark finding in **Turner syndrome (XO)** due to lymphatic system malformation.
- Turner syndrome typically presents with different prenatal markers, such as **cystic hygroma** and often normal maternal serum screen values (or specific patterns not matching the profile given).
Question 48: A 55-year-old postmenopausal woman comes to the physician for a screening Pap smear. She has no history of serious illness. Her last Pap smear was 10 years ago and showed no abnormalities. She has smoked one-half pack of cigarettes daily for 20 years and drinks 3 bottles of wine per week. She is sexually active with multiple male partners and uses condoms inconsistently. Her paternal grandmother had ovarian cancer and her maternal aunt had breast cancer. Pelvic examination shows multiple red, fleshy polypoid masses on the anterior vaginal wall. A biopsy is obtained and histology shows large cells with abundant clear cytoplasm. Which of the following is the most significant risk factor for this diagnosis?
A. Family history of breast and ovarian cancer
B. Human papillomavirus infection
C. Alcohol consumption
D. Diethylstilbestrol exposure in utero (Correct Answer)
E. Cigarette smoking
Explanation: ***Diethylstilbestrol exposure in utero***
- The patient's presentation with **clear cell carcinoma of the vagina**, characterized by **red, fleshy polypoid masses** and **large cells with abundant clear cytoplasm**, is highly suggestive of this diagnosis.
- **In utero exposure to diethylstilbestrol (DES)** is a classic and significant risk factor for the development of clear cell adenocarcinoma of the vagina and cervix.
*Family history of breast and ovarian cancer*
- While a family history of breast and ovarian cancer may indicate an increased risk for other gynecological cancers (e.g., BRCA mutations), it is **not directly linked** to clear cell adenocarcinoma of the vagina.
- This family history points more towards **hereditary breast and ovarian cancer syndromes**, not the specific pathology described.
*Human papillomavirus infection*
- **HPV infection** is a major risk factor for most cases of **squamous cell carcinoma of the vagina and cervix**, and also increases the risk of adenocarcinoma of the cervix.
- However, HPV is **not a primary risk factor for clear cell adenocarcinoma of the vagina**, which has a distinct etiology.
*Alcohol consumption*
- While excessive **alcohol consumption** can be associated with an increased risk of certain cancers, it is **not a specific or significant risk factor** for clear cell adenocarcinoma of the vagina.
- It generally contributes to a broad range of cancers rather than specific rare forms.
*Cigarette smoking*
- **Cigarette smoking** is a well-established risk factor for **squamous cell carcinoma of the cervix and vagina**, among other cancers.
- However, it is **not a recognized significant risk factor** for the development of **clear cell adenocarcinoma of the vagina**.
Question 49: A 27-year-old G1P0 female presents for her first prenatal visit. She is in a monogamous relationship with her husband, and has had two lifetime sexual partners. She has never had a blood transfusion and has never used injection drugs. Screening for which of the following infections is most appropriate to recommend this patient?
A. Syphilis and HIV
B. Syphilis, HIV, and HBV (Correct Answer)
C. Syphilis, HIV, HBV, and chlamydia
D. Syphilis, HIV, and chlamydia
E. No routine screening is recommended for this patient
Explanation: ***Syphilis, HIV, and HBV***
- The **American College of Obstetricians and Gynecologists (ACOG)** and the **Centers for Disease Control and Prevention (CDC)** recommend universal screening for syphilis, HIV, and hepatitis B virus (HBV) in all pregnant women at the first prenatal visit.
- This **routine screening** is crucial due to the potential for vertical transmission and severe adverse outcomes for the neonate if untreated.
*Syphilis and HIV*
- While screening for syphilis and HIV is essential, it is **incomplete** as it omits HBV, which is also universally recommended for antenatal screening.
- This option does not align with the standard comprehensive screening guidelines for pregnancy.
*Syphilis, HIV, HBV, and chlamydia*
- Although syphilis, HIV, and HBV screening are appropriate, adding **chlamydia** to the universal prenatal screening for *all* pregnant women in the first trimester is not standard practice unless specific risk factors are present or local prevalence is high.
- Chlamydia screening is typically recommended for pregnant women who are **25 years or younger** or those with **risk factors** for sexually transmitted infections (STIs).
*Syphilis, HIV, and chlamydia*
- This option incorrectly includes chlamydia as a universal screen for all pregnant women while **omitting HBV**, which is universally recommended.
- Missing HBV screening leaves a critical gap in prenatal care, as it can be transmitted vertically and cause severe neonatal disease.
*No routine screening is recommended for this patient*
- This statement is incorrect as **universal screening** for syphilis, HIV, and HBV is recommended for all pregnant women, regardless of reported risk factors or monogamous relationships.
- Maternal infection can still occur, and screening helps prevent severe outcomes for both mother and child through timely detection and intervention.
Question 50: An 18-year-old woman presents for a routine check-up. She is a college student with no complaints. She has a 2 pack-year history of smoking and consumes alcohol occasionally. Her sexual debut was at 15 years of age and has had 2 sexual partners. She takes oral contraceptives and uses barrier contraception. Her family history is significant for cervical cancer in her aunt. Which of the following statements regarding cervical cancer screening in this patient is correct?
A. The patient requires annual Pap testing due to her family history of cervical cancer.
B. HPV testing is more preferable than Pap testing in sexually active women under 21 years of age.
C. It is reasonable to start Pap-test screening at the current visit and repeat it every 3 years.
D. The patient should undergo screening every 3 years after she turns 21 years of age. (Correct Answer)
E. The patient does not require Pap testing as long as she uses barrier contraception.
Explanation: **The patient should undergo screening every 3 years after she turns 21 years of age.**
- Current guidelines recommend initiating cervical cancer screening at **age 21**, regardless of sexual activity.
- The recommended interval for cytology-only screening is **every 3 years** for women aged 21-29.
*The patient requires annual Pap testing due to her family history of cervical cancer.*
- **Family history of cervical cancer** is generally not considered a reason for earlier or more frequent screening in individuals under 21 years of age, unless specific genetic syndromes are suspected, which is not mentioned here.
- The primary risk factor for cervical cancer is **HPV infection**, not direct family history.
*HPV testing is more preferable than Pap testing in sexually active women under 21 years of age.*
- **HPV testing** as a primary screening method is **not recommended for women younger than 25** due to the high prevalence of transient HPV infections that resolve spontaneously in this age group.
- Over-screening and subsequent interventions could lead to unnecessary anxiety and procedures for conditions that would likely resolve on their own.
*It is reasonable to start Pap-test screening at the current visit and repeat it every 3 years.*
- Starting screening at the current age of **18 years is not recommended** according to current guidelines, as screening typically begins at age 21.
- Early screening in this age group often leads to the detection of **transient HPV infections** that would otherwise resolve without intervention, causing undue stress and follow-up.
*The patient does not require Pap testing as long as she uses barrier contraception.*
- While **barrier contraception** (condoms) reduces the risk of HPV transmission, it does not eliminate it entirely and therefore **does not negate the need for cervical cancer screening.**
- Regular screening is still recommended to detect any persistent HPV infections and associated cervical changes early.